ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13300; 2) Community: the network communities that were significantly associated with the response to NSC 13300; 3) Molecule: the relationships between components within communities and NSC 13300; 4) MDR: the compounds that were significantly associated with the NSC 13300.

NSC Compound Enrichment Correlation
NSC 747448 3,19-(2,6-Dimethyoxy)benzylidineandrographolide 0.0376362543535812 0.1375412
NSC 75140 Benzenesulfonamide, 4-[(6,7-dihydro-6-thioxo-1H-purin-8-yl)azo]- 0.0376362543535812 0.16583031
NSC 754824 4-[4-(3-Methoxy-phenyl)-piperazin-1 -yl]-5H-pyrrolo[3,2-d]pyrimidine 0.0376362543535812 0.21996902
NSC 756738 DIGOXIN 0.0376362543535812 -0.30645111
NSC 77830 Cycloguanil Pamoate (USAN) 0.0376362543535812 0.098836885
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 0.0376362543535812 0.2026262
NSC 112965 Null 0.0376362543535815 -0.071785311
NSC 174121 Methotrexate Derivative 0.0382675857669587 0.14870914
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.0382675857669587 0.060124363
NSC 382001 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(2,5-dimethyl phenyl)-, hydrochloride 0.0382675857669587 0.40091682
Total:57  Current:45    [First] [Prev] [Next] [Last]